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Abstract
BACKGROUND: Recurrent respiratory tract infections (RRI) are one of the extremely high common reasons for 
pediatric visits and hospitalization. Immunodeficiencies are considered as important conditions that may increase the 
probability of occurrence of RRI. Mannose-binding lectin (MBL2) is a protein of the innate immune system involved 
in the opsonization and the complement activation. MBL2 deficiency is associated with infectious diseases mainly 
chest infections; however, subnormal MBL2 levels are also seen in healthy subjects. Primary immunedeficiencies are 
associated with recurrent infections which mainly appear in early childhood.
AIM: The aim of the study was to estimate T and B and natural killer cells percentage and to investigate the MBL2 
and immunoglobulins (Igs) serum levels in children with recurrent RRIs in different genetic disorders compared to 
normal control.
METHODS: This study included 50 children having a history of recurrent RRIs. All patients had genetic disorders and 
referred to National Research Centre for follow-up, in addition to, 25 children, age- and sex-matched as a healthy 
control group. They were subjected to full clinical examination and laboratory investigations including complete blood 
count (CBC), CD3, CD4, CD8, CD16, and CD19 by flow cytometry, MBL2 by enzyme-linked immunosorbent assay 
(ELISA), and Igs serum concentrations by nephelometry.
RESULTS: CD16 showed a non-statistical significant difference between both patient groups. Serum levels of 
IgA in patient groups showed a significant decrease compared to the control group. Moreover, the serum level of 
IgM results shows a highly significant decrease when compared with the control group. There was no statistically 
significant difference in MBL2 and IgG serum levels between patient groups and control group.
CONCLUSION: Children with genetic disorders and recurrent RRIs showed a statistically significant decrease of 
IgA and IgM serum levels as compared to the control group, while the serum level of MBL2 did not show significant 
results.
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Introduction
Respiratory tract infections (RRIs) are a 
worldwide problem, and one of the first causes of 
morbidity and mortality in childhood, the causes of 
susceptibility are poorly defined. Recurrent RRI is the 
most common sign of the ten warning signs of primary 
immunedeficiency (PID) [1]. Recurrent respiratory 
infections in childhood influence the bronchoalveolar 
and the vascular development of the lungs. This causes 
many long-term complications. The early treatment, 
depending on the etiology, has to be initiated. The World 
Health Organization data demonstrated that children 
may present, annually, during their first 5 years of their 
life, with 4–8 incidents of respiratory infections that affect 
mainly lower respiratory system. Respiratory infections 
are considered as recurrent diseases from three 
incidents of acute infections during a 6 months period [2].
Mannose-binding lectin (MBL) is a serum 
protein, a pattern recognition molecule of the 
innate immune defense. It is protein belongs to the 
collectin family, which includes surfactant proteins A 
and D, with a parallel function and structure. It binds 
carbohydrates as mannose which is found on the 
surfaces of many pathogens that make the activation of 
the complement pathway so facilitating phagocytosis. 
Direct opsonization similarly occurs through collectin 
receptors on the phagocyte surface. Many studies 
showed that MBL2 variants could be weakly associated 
with increased susceptibility to numerous infections [3]. 
MBL deficiency is considered as the main inherited 
immunodeficiency in humans, with an incidence of 5% 
homozygote and 30% heterozygote [4]. Deficiency is 
associated with susceptibility to recurrent infections 
usually as upper respiratory, abscess, meningococcal 
disease, and sepsis [5], [6]. Low serum levels of MBL2 
are accompanied by perinatal infections [7].
Immunoglobulins (Igs) are essential mediators 
of humoral immunity by neutralization, opsonization, 
and phagocytosis of the pathogens as well as the 
complement activation. Immunodeficiency patients are 
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typically evaluated by the clinical presentation and early 
screening tests with (complete blood count [CBC]), Ig 
levels, and estimation of lymphocyte subsets [8]. Early 
diagnosis of PIDs can improve their outcome and quality 
of life, and help to prevent debilitating complications [9]. 
Immunophenotyping by flow cytometry and quantization 
of peripheral blood lymphocyte subsets could be either 
diagnostic or prognostic useful in numerous PIDs but 
not all [10].
PID is frequently associated with recurrent 
infections presenting in early childhood and is mainly 
caused by non-virulent microorganisms [11]. Antibody-
mediated immune system deficiencies are considered 
an important risk of recurrent infections, especially 
the RRI by encapsulated bacteria [12], [13]. Several 
studies reported an association between low level of 
Igs, disease severity, and unfavorable outcomes in 
patients with sepsis [14].
The aim of this study is to estimate MBL2 and 
Igs levels in patients with recurrent RRI either with 
decreased immune cells or normal levels of immune 
cells as compared to the normal control.
Methods
This study included 50 patients. They had 
different genetic disorders and were presenting with 
recurrent chest infections and attending Clinical 
Genetics Clinic National Research Centre for follow-up. 
This research was approved by the Medical Ethical 
Committee of the National Research Centre, Egypt 
(ethics number; 16108), according to the World Medical 
Association Declaration of Helsinki. Written consent 
was taken from each patient guardian. All patients 
and controls were subjected to full medical history 
and clinical examination. Laboratory investigations, 
including CBC and immune cells measurements by 
flow cytometry revealed altering immune profile for 
some of them. After flow cytometry estimation of T, B 
lymphocytes and natural killer (NK) cells, they were 
categorized into two groups, Group 1; n = 25 patients 
with a recurrent chest infection and low T, and or B cells 
and or NK and Group 2; n = 25 recurrent chest infections 
and normal level of T, B, and NK cells, in addition to 25 
children as a healthy control group (Group 3), age- and 
sex-matched.
Blood samples were obtained from all patients 
during the first contact with the physician, and at the 
time of diagnosis, and serum was separated and stored 
at −80°C until analysis.
Flow cytometry studies
Peripheral blood CD3%, CD4%, CD8%, 
CD19%, and CD16% for all patients were estimated 
according to manufacture steps using monoclonal 
antibodies (BD Biosciences, USA) by flow cytometry 
procedure [15]. Isotype-matched controls were 
performed for every analysis for the evaluation of 
possible non-specific staining and autofluorescence.
Estimation of MBL2 level
Serum levels of MBL2 in patients and controls 
were measured by ELISA using the AviBion Human 
MBL2 ELISA kit (Ani Biotech Oy, Vantaa, Finland) as 
the manufacturer’s protocol.
Estimation of serum Igs levels
Serum IgA, IgM, and IgG levels in patients and 
controls were monitored by nephelometry immunoassay 
using (MininephTM, the Binding Site Ltd, PO Box 11712, 
Birmingham, B14 4ZB, U.K) as the manufacturer’s 
protocol.
Statistical analysis of data
Data are expressed as mean ± SD. Statistical 
significance of the difference was analyzed using 
SPSS version 20. p < 0.05 was considered statistically 
significant.
Results
This study included 50 patients, their age 
ranged from 1 year to 9 years; they were 29 males and 
21 females, in addition to, 25 healthy control subjects’ 
age- and sex-matched (Table 1).
Table 1: Age and sex in the three groups
Parameters Group 1 (n=25) Group 2 (n=25) Control (n=25)
Age range (years) 1–6 2–9 1–9
Sex
Males 14 15 19
Females 11 10 6
There was a highly statistically significant 
difference between Group 1 and Group 2 as regard 
CD3 (p = 0.0029) and statistically significant difference 
with CD4, CD8, and CD19 (p = 0.0052, 0.0301, and 
0.0265), respectively (Table 2).
Table 2: Flow cytometry estimation of T, B, and NK cells Mean±SD
Parameters Group 1 (n=25) Group 2 (n=25) p-value
CD3% 35.39±21.26 54.39±8.81 0.0029
CD4% 21.11±9.91 32.88±10.05 0.0052
CD8% 10.46±6.21 17.23±8.82 0.0301
CD19% 11.70±9.21 17.94±5.31 0.0265
CD16% 14.55±6.84 16.17±6.39 0.5589
p<0.05. NK: Natural killer, SD: Standard deviation.
Serum levels of IgA in Group 1 and Group 2 showed 
a significant decrease (p = 0.0114 and 0.0316, 
respectively) from the control group, while IgM results 
show a highly significant decrease in both groups 
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(p = 0.0032 and 0.0024, respectively) as compared 
to the control group but non-statistically significant 
difference in IgG and MBL2 (Table 3).
Table 3: Serum MBL2 and immunoglobulins levels (Mean±SD) 
in the three studied groups
Parameters Group 1 
n=25
Group 2 
n=25
Group 3 
(Control) n=25
p-value (Group 
1 and C)
p-value (Group 
2 and C)
MBL2 (ng/ml) 3.16±3.78 1.38±0.77 2.89±2.40 0.8840 0.0856
IgA (g/L) 0.42±0.34 0.73±0.29 1.31±0.98 0.0114 0.0316
IgM (g/L) 0.57±0.36 0.75±0.24 1.41±0.56 0.0032 0.0024
IgG (g/L) 7.56±2.18 9.01±2.04 9.62±3.20 0.1398 0.5985
p<0.05. MBL2: Mannose-binding lectin 2, Ig: Immunoglobulin, SD: Standard deviation.
Discussion
MBL is a liver-derived complement-activating 
protein; it acts as an opsonin that recognizes 
repetitive sugar molecules present in many species 
of microorganisms. The MBL2 gene has several 
common polymorphisms that can affect the function or 
concentration of the protein [16].
The current study included 50 children patients 
with age range from 1 year to 9 years, referred to 
Clinical Genetics Clinic, National Research Centre 
with a history of recurrent chest infections. After flow 
cytometry estimation of CD3%, CD4%, CD8%, CD19%, 
and CD16%, the patients in this study were divided into 
two groups: Group 1, n = 25, 14 males and 11 females, 
with associated immune cells defects and Group 2, 
n = 25, 15 males and 10 females without associated 
immune cells deficiency in different genetic disorders. 
The study had a control Group 3 of 25 healthy children 
with age- and sex-matched (Table 1).
Flow cytometry is a highly sensitive method 
for evaluating the immune system and facilitating 
the diagnosis of PID [10]. Our results revealed a 
statistically significant decrease in CD4%, CD8%, and 
CD19% in Group 1 as compared to Group 2 (p < 0.05). 
CD3 showed a high statistically significant decrease 
in Group 1 than Group 2 (p < 0.005). CD16 showed 
no statistically significant difference between groups 
(p > 0.05) (Table 2). Stepensky et al. found a decrease 
in CD4% and not CD16% during his study that was done 
on severe combined immunodeficiency [17]. This is in 
agreement with Shearer et al. stated that the principal 
immunologic change documented in multicenter, 
longitudinal studies were that CD4+ T-lymphocytes 
decreased rapidly in infected infants and children [15].
Our study demonstrated no significant 
difference between MBL2 serum levels in patients 
having recurrent chest infection either with or without 
associated immune cells deficiencies in different genetic 
disorders patients in both groups Group 1 and Group 2, 
respectively, compared to the control group (Group 3) 
(p > 0.05) (Table 3). This is in agreement with Atan et al. 
who demonstrated no statistically significant correlation 
between MBL2 genotype and the occurrence of 
recurrent RRI in children [18]. Furthermore, our results 
are in agreement with Jørgensen et al. who studied 
MBL in both recurrent respiratory infection and severe 
combined immune deficiency groups; they suggested 
that MBL is not increased in patients with immunological 
dysregulation than in healthy subjects [19]. In another 
study population, MBL deficiency had no association 
with microbial etiology. Low levels of Igs and MBL2 
were not associated with the etiology, nor the severity, 
or the outcome in community-acquired pneumonia [20]. 
Ishii et al. postulated that MBL2 deficiency is not a risk 
factor for severe life-threatening infections [21].
MBL2 variant alleles are associated with an 
increased risk of infections [22]. Koch et al. stated 
that MBL2 plays an important role in acute respiratory 
infection in vulnerable children aged 6–17 months [23]. 
Another population-based study did not find any 
significant differences in infectious disease in MBL2-
deficient adult patients [24]. On the other hand, 
Hoeflich et al. and Rantala et al. studies showed an 
association between the MBL deficiency and increased 
susceptibility for infections without suffering from other 
immunodeficiencies [25,26].
In the present study, serum levels of IgA in 
Group 1 and Group 2 showed a significant decrease 
(p < 0.05) from the control group, while IgM results 
show a highly significant decrease (p < 0.005) when 
compared with the control group (Table 3).
There was no statistically significant difference 
between IgG serum levels between patients (Group 1 
and 2) and control group (p > 0.05) (Table 3). This is 
in agreement with Stepensky et al. who detected a 
decrease in the three Igs levels [17]. Cohen et al. also 
stated that the participation of immunodeficiencies is 
weak as compared to other causes and it is remarkable 
that the immunodeficiency is showed only by recurrent 
RRIs, without association with infections of other 
sites [2].
B lymphocyte disorders may lead to a decrease 
in Igs serum levels. Siebert et al. in his study on B cell 
numbers in children having recurrent lower respiratory 
infections compared with control, found a significant 
increase in Igs synthesized cells numbers, but the 
median values of B cells in both groups (recurrent RRIs 
patients and healthy subjects) were still in the normal 
ranges for both age and gender [27].
Recurrent respiratory infection (RRI) when 
associated with IgA deficiency, a complex of primary 
immunodeficiency, as ataxia telangiectasia, may 
be considered, and a serum alpha-fetoprotein 
measurement, a lymphocyte phenotyping and oriented 
karyotyping should be achieved [28]. Moreover, 
inflammation in infectious disease is self-limiting 
the absence of antigen-specific T cells and tissue 
damage [29].
Raniszewska et al. found no significant 
difference in B cell numbers; only 25% of his studied 
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group of children had decreased CD19 cell numbers 
and no subjects with increased B cells. RRI is not 
only connected with abnormalities in neutrophils and 
B cells but also a defective or decreased number of 
T cells may lead to recurrent infections, which may 
include opportunistic pathogens [30]. It is clear that 
immunity reaches high efficacy in the 5th or 6th years 
of age [31]. Hence, several children with RRI may not 
have immunodeficiency. The cause of RRI may be the 
childhood itself. However, it could be a warning sign for 
a physician, in which the RRI is important to detect or 
exclude disorders associated with immunodeficiency. 
Early immunological assessment can allow effective 
Ig replacement therapy in B cell deficiency. In T cell or 
granulocytes disorders, antibiotic or antiviral prophylaxis 
should be applied [32].
Conclusion
IgA and IgM serum levels showed a statistically 
significant decrease in patients with genetic disorders 
and having recurrent respiratory infections as compared 
to the normal control group.
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